Pharmaceutical manufacturer Merck Sharp & Dohme Corp. has announced it will give refunds to 340B providers that bought certain products between 2002 and 2013. [ms-protect-content id=”2799″] The refunds are a result of a recently recalculated Average Manufacturer Price and Best Price values.
The items eligible for refunds include Remeron, Desogen, Implanaon, NuvaRing, Mircette, Cyclessa, Follistim, among others. A full list of products with corresponding national drug codes and relevant time frames is available here.
The company will be reaching out to 340B covered entities that are due refunds. Hospitals should direct inquiries to Organon_340B_Refund@merck.com. [/ms-protect-content]